معلومات عن هذه الحلقة
Stanford's Branimir Sikic discusses the importance of, and offers guidance to achieve the development of personalized medicines that are risk adapted genomic guided therapies which make a major impact on the disease. (September 15, 2008)
الإنجليزية
الولايات المتحدة
النص 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
البحث في الحلقات الماضية
البحث في الحلقات السابقة من Comprehensive Cancer Research Training Program.
حلقات أخرى في هذا البودكاست
Dr. Saul Rosenberg discusses the history of diagnosis and treatment of Hodgkin's Disease and the remarkable improvement in curability since the 1960's. (September 15, 2008)
Frank McCormick discusses how each protein is a problem in the use of pharmaceutics to combat cancer and suggests that developing a platform that can be used for anything is the process that will alter the future of cancer treatment. (September 16, 2008)
Dr. Michael Cleary discusses this work on the role of chromosomal aberrations in causing cancer and its implications for cancer treatment. (September 18, 2008)
Anthony Oro, MD, PhD, discusses how Hedgehog signally is a model for a variety of morphogenetic signals, that taking stem cells to effect wound healing may have an important role in pathogenesis. (September 16, 2008)
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من Stanford University، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.
